Morning Overview on MSN
Psilocybin may break depression loops by reshaping brain wiring
Psilocybin, the psychoactive compound in so-called magic mushrooms, is emerging as one of the most intriguing tools in modern ...
Could psilocybin be on a trip to become a standard treatment for depression? Well, things are looking quite promising if you read the ‘shroom correctly. The latest evidence comes from a Phase 2 ...
2don MSN
Psilocybin shows greater potential than cannabinoids for obsessive-compulsive disorder treatment
In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for ...
Do you believe in magic? Studies that support the use of psychedelics to treat mental health problems are popping up like mushrooms. Yesterday, the Journal of the American Medical Association ...
By combining psilocybin with a modified rabies virus that tracks neural connections, they mapped how networks change after a ...
ScienceAlert on MSN
Psilocybin Breaks Depressive Cycles by Rewiring The Brain, Study Suggests
Scientists have used a specially engineered virus to help track the brain changes caused by psilocybin in mice, revealing how ...
Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...
In recent years, the psychedelic compound psilocybin found in magic mushrooms has been widely tested for its antidepressant ...
Meta-analysis found that high-dose psilocybin was more effective than placebo in treating depressive symptoms in antidepressant trials, though its effect size was small compared to escitalopram. In a ...
An international collaboration led by Cornell University researchers used a combination of psilocybin and the rabies virus to map how – and where – the psychedelic compound rewires the connections in ...
Synthetic psilocybin with psychotherapy was effective and safe for patients with treatment-resistant bipolar depression, a small nonrandomized controlled trial suggested. Among 15 people with bipolar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results